According to the Zhitong Finance App, Zhongsheng Beijing Holdings Biotechnology (08247) announced results for the six months ended June 30, 2026. The group achieved operating income of RMB 83.32 million during the period, a decrease of 14.12%; net loss attributable to shareholders of the parent company was RMB 8.331 million, a year-on-year narrowing of 53.65%; and a basic loss of 0.06 yuan per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.